drugset / Trial / NCT06788314

A Study of Enalapril in Treatment of Venous Malformations

NCT06788314

Phase 2 Recruiting 12 enrolled Oslo University Hospital
NaSingle-groupOpen-labelTreatment

Summary

The goal of this clinical trial is to explore if enalapril can be used to treat painful venous malformations. The main question it aims to answer are: \- Can enalapril reduce pain and volume of the malformation and increase quality of life in patients with painful venous malformations? Participants will: Receive a dose of enalapril 5 mg once daily. If it doesn't have effect the dose of enalapril will be increased to 10 mg daily after 3 months. The treatment duration will be 12 months, with an additional follow-up of 12 months. The visit frequency will be after 1, 3, 6,9 and 12 months and then a follow up visit at 18 and 24 months. Approximately 15 participants will be screened to achieve minimum 10 enrolled participants.

Timeline

Start
2025-02-01
Primary completion
2029-12-01
Completion
2030-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Enalapril Other / unclassified 5 mg
Subject Enalapril Other / unclassified 10 mg